Cargando…
CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a chronic multisystemic autoimmune disease with an unknown etiology. Recently, it has been elucidated that dysregulated histone deacetylase (HDAC) activity is related to the pathogenesis of inflammatory and autoimmune diseases. Broad-spectrum HDAC inhibitors are...
Autores principales: | Choi, Eun Wha, Song, Ji Woo, Ha, Nina, Choi, Young Il, Kim, Sungjoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251916/ https://www.ncbi.nlm.nih.gov/pubmed/30470828 http://dx.doi.org/10.1038/s41598-018-35602-1 |
Ejemplares similares
-
CKD-506: A novel HDAC6-selective inhibitor that exerts therapeutic effects in a rodent model of multiple sclerosis
por: Bae, Daekwon, et al.
Publicado: (2021) -
Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis
por: Park, Jin Kyun, et al.
Publicado: (2020) -
A novel HDAC6 inhibitor, CKD-504, is effective in treating preclinical models of huntington’s disease
por: Li, Endan, et al.
Publicado: (2023) -
Relationship between neutrophil gelatinase-associated lipocalin levels and
disease parameters including clinicopathological parameters and various cytokine levels in
systemic lupus erythematosus
por: CHOI, Eun Wha
Publicado: (2023) -
Effects of high fat diet-induced obesity on pathophysiology, immune cells, and therapeutic efficacy in systemic lupus erythematosus
por: Choi, Eun Wha, et al.
Publicado: (2022)